The antibiotic is active against Gram-positive and -negative bacteria on a synthetic medium.
The inhibitory activity is reversed by L-glutamine and L-glutamic acid.
In Spira type. The spores are cylindrical. The spore surface is smooth with some winkled forms.
Sclerotic granules, sporangia and flagellated spores were not observed.
Chemotaxonomy
The chemical analyses of sugars in whole cells and diaminopimelic acid (AZpm) in cell wall were carried out by the methods of LECHEVALIER and LECHEVALIER.' Strain AM-6424 showed presence of LL-AZpm in the cell wall and no characteristic sugar pattern.
Cultural and Physiological Characteristics
The International Streptomyces Project (ISP) media recommended by SHIRLING and GOTTLIEB2>
and those recommended by WAKSMAN3) were used. Cultures were observed after incubation at 27°C
for two weeks. Color names and hue numbers indicated in Table 1 Strain AM-6424 exhibits the following properties. Sporophore, Spira; spore, cylindrical; spore surface, smooth; color of vegetative mycelium, gold or brown; color of aerial mycelium, white or ivory;
production of melanoid pigment, active; soluble pigment, yellow or gold; A2pm in cell wall, LL-type. Based on the taxonomic properties described above, strain AM-6424 is considered to belong to the genus Streptomyces and to be a strain of the white series of the PRIDHAM and TRESNER grouping'). Strain AM-6424 has been deposited in Fermentation Research Institute, Agency of Industrial Science and Technology, Japan, under the name Streptomyces sp. AM-6424 and the accession No. FERM-P 6791.
Production and Isolation
The stock culture of strain AM-6424 was inoculated into 100 ml of a seed medium consisting of 2 glucose, 0.5 % meat extract, 0.5 % peptone, 0.3 % dried yeast, 0.5 % NaCl and 0.3 % CaCO3 in a 500-ml Sakaguchi flask and incubated at 27°C for 48 hours. Three hundred milliliters of a thus obtained seed culture was transferred to 30 liters of a production medium in a 50-liter jar fermentor and the fermentation was carried out at 27°C with agitation of 250 rpm and aeration of 10 liters/minute. The composition of the production medium was 2 % starch, 0.5 % glycerol, 0.25 % soybean meal, 0.5 % NH4CI, 0.1 SEPT. 1983 KZHPO4 and 0.15% Ca,(PO4), (presterile pH 6.8). The antibiotic production started at 15-20 hours after inoculation then gradually increased and reached a maximum (2 ,ug/ml) at 39 hours.
A 42-hour culture (30 liters) was clarified with a Sharples centrifuge to obtain about 28 liters of a supernatant fluid. The fluid was adjusted to pH 7.2 with 2 N NaOH and treated with 500 ml of Amberlite IRC-50 (Na+) in a batchwise operation. The antibiotic in the effluent was adsorbed on an activated carbon column (20 x 9 cm), and eluted with 40 % acetone. The active fractions were combined, concentrated in vacuo to a small volume and lyophilized to obtain 41.6 g of crude powder. The powder was chromatographed on an Avicel column (45 x 6.5 cm), eluting with a mixed solvent of methanol and water (6: 1). The active fractions were combined, concentrated in vacuo to 100 ml and lyophilized to give 820 mg of yellowish brown powder. The powder was dissolved in 1 ml of water and applied on a Sephadex LH-20 column (90 x 3 cm) previously equilibrated with water. The antibiotic was eluted with water. The active fractions were combined, concentrated in vacuo to 10 ml and lyophilized to give a pale yellow powder (40 mg). The antibiotic was then purified by preparative thin-layer chromatography (TLC) on Avicel developing with 1-butanol -acetic acid -water (3: 1: 1). The active zone was cut out from TLC and eluted with water. The eluate was concentrated in vacuo to 1 ml and lyophilized to give a pale yellow powder (16.6 mg). The powder was dissolved in 0.5 ml of water and chromatographed on Sephadex LH-20 column eluting with water. The active fraction were combined, concentrated in vacuo to 1 ml and lyophilized to yield 5.5 mg of pure karabemycin as a white powder .
The antibiotic activity was assayed by paper disc method against Bacillus subtilis PCI 219 on synthetic agar plates. The antibiotic was also detected by Avicel TLC: Solvent , 1-propanol -pyridine - (Fig. 3) . From the analyses mentioned above, karabemycin is considered to be a tripeptide antibiotic. A, root length in non-treated class B, root length in treated class with karabemycin Five milliliters of karabemycin aqueous solution was added to a Petri dish (7.5 cm in diameter). Five seeds of Oryzae sativa or Raphanus sativus per dish were inoculated into the Petri dish. The seeds were incubated at 25°C for 5 days under a fluorescent lamp. Table 5 shows the antimicrobial spectrum of karabemycin.
Biological Properties
The antibiotic was active against some bacteria on a synthetic agar medium, but was inactive or weakly active against bacteria on a complex agar medium and was inactive against fungi. The inhibitory activity of karabemycin against bacteria on a synthetic agar medium was reversed by L-glutamine and L-glutamic acid.
Karabemycin has inhibitory activity on the growth of plant roots (Table 6 ). Karabemycin (500 jig/ml) did not show any toxic symptoms to RK-13 cells grown in tissue culture.
Discussion
Karabemycin was isolated from the culture filtrate of Streptomyces sp. AM-6424. The antibiotic was found to be an antimetabolite of glutamine (glutamic acid), and a tripeptide antibiotic consisting of alanine, valine and an unidentified amino acid.
Karabemycin was compared with known antibiotics of actinomycetes origin, such as antimetabolites of glutamine (glutamic acid) and peptide antibiotics. However, because none of their physicochemical properties was identical with those of karabemycin, it is reasonable to conclude that karabemycin is new.
A paper describing structure elucidation of karabemycin is now in preparation.
